ACR Releases Summary of MedPAC March Report
Highlighting MedPACās March findings on Medicare spending, payment adequacy, and key recommendations for physicians and hospitals.
Read moreFunding for the National Institutes of Health (NIH) in federal fiscal year (FY) 2026 is uncertain until Congress returns from its August recess. Before lawmakers departed to their respective congressional districts, the U.S. House Committee on Appropriations approved updated FY 2026 appropriations allocations for all of its subcommittees; this includes allocations for the Labor, Health and Human Services, Education, and Related Agencies (LHHS) subcommittee, which sets NIH funding in the House.
The LHHS allocation in the House is $184.5 billion, approximately $1.3 billion less than its FY 2025 funding levels, but not as drastic as what was previously included in the President’s Budget Proposal. Committee members will consider changes — known as “markup” — to NIH’s share of the $184.5 billion allotted when back in September.
ACR® advocacy is ongoing for increased funding levels for NIH and the Advanced Research Projects Agency for Health. The College and other healthcare associations, including the Ad Hoc Group for Medical Research, seek at least $51.3 billion for the NIH in FY 2026.
The U.S. Senate has not released a markup schedule that includes their LHHS appropriations bill. The current fiscal year funding ends Sept. 30.
For more information, contact Katie Grady, ACR Government Affairs Director.
ACR Releases Summary of MedPAC March Report
Highlighting MedPACās March findings on Medicare spending, payment adequacy, and key recommendations for physicians and hospitals.
Read moreState AI Healthcare Bills Draw ACR Attention
State legislatures are advancing AI healthcare bills targeting insurer denials, clinical guardrails, and transparency for AI use in care and coverage.
Read moreACR Backs Fix to Burdensome Noridian TPE Reviews
ACR urges Noridian to end prepayment reviews of radiologistsā professional components, citing access barriers and high denial rates.
Read more